Skip to main content
. 2019 Mar 28;10:290. doi: 10.3389/fneur.2019.00290

Table 2.

Summary ORs and 95% CI of ALDH2 polymorphisms and AD and PD risk.

N* OR 95% CI P I2(%) OR 95% CI P I2(%) OR 95% CI P I2(%) OR 95% CI P I2(%) OR 95% CI P I2(%)
rs671 A vs. G GA vs. GG AA vs. GG GA+AA vs. GG AA vs. GG+GA
AD Total 6 1.46 1.01–2.11 0.05 84.2 1.35 0.91–1.99 0.13 73.9 2.22 1.03–4.77 0.04 79.2 1.36 0.90–2.03 0.14 81.0 1.94 1.03–3.64 0.04 71.1
HWE–yes 4 1.48 0.88–2.49 0.14 87.4 1.26 0.72–2.21 0.41 79.4 2.57 1.01–6.53 0.05 78.1 1.45 0.77–2.73 0.25 86.0 2.23 1.18–4.60 0.01 61.4
HWE–no 2 1.36 1.10–1.69 0.01 NA 1.60 1.21–2.12 0.001 NA 1.33 0.78–2.27 0.29 NA 1.19 0.64–2.18 0.58 76.4 1.11 0.66–1.87 0.69 NA
COUNTRY
China 3 1.64 0.87–3.10 0.12 88.3 1.39 0.67–2.85 0.38 83.0 3.15 1.03–9.65 0.04 79.6 1.63 0.74–3.62 0.23 87.9 2.75 1.23–6.14 0.02 63.0
Japan 2 1.54 1.00–2.36 0.05 17.1 1.28 0.77–2.13 0.33 69.7 1.34 0.85–2.12 0.20 0 1.31 0.87–1.98 0.20 59.6 1.18 0.76–1.85 0.46 0
CONTROL DESIGN
HB 4 1.57 1.02–2.42 0.04 86.0 1.47 0.95–2.27 0.09 74.6 2.48 0.98–6.30 0.06 83.4 1.63 0.99–2.67 0.05 82.7 2.10 0.96–357 0.06 77.6
PB 2 1.07 0.75–1.54 0.71 NA 0.95 0.58–1.55 0.84 NA 1.38 0.57–3.35 0.48 NA 0.93 0.65–1.32 0.68 0 1.41 0.60–3.34 0.43 NA
SUBJECTS
>500 2 1.36 1.10–1.69 0.01 NA 1.60 1.21–2.12 0.001 NA 1.33 0.78–2.27 0.29 NA 1.19 0.64–2.18 0.58 76.4 1.11 0.66–1.87 0.69 NA
< 500 4 1.48 0.88–2.49 0.14 87.4 1.26 0.72–2.21 0.41 79.4 2.57 1.01–6.53 0.05 78.1 1.45 0.77–2.73 0.25 86.0 2.23 1.18–4.60 0.01 61.4
NOS EVALUATION
NOS < 8 5 1.57 1.02–2.42 0.04 86.0 1.47 0.95–2.27 0.09 74.6 2.48 0.98–6.30 0.06 83.4 1.43 0.90–2.28 .92–2.18 0.13 82.9 2.10 0.96–357 0.06 77.6
NOS ≥8 1 1.07 0.75–1.54 0.71 NA 0.95 0.58–1.55 0.84 NA 1.38 0.57–3.35 0.748 NA 1.01 0.64–1.61 0.96 NA 1.41 0.60–3.34 0.43 NA
GENDER
Male 2 1.52 1.06–2.16 0.02 0 1.70 1.07–2.70 0.03 14.3 1.81 0.73–4.46 0.20 0 1.72 1.10–2.67 0.02 0 1.47 0.60–3.58 0.40 0
Female 2 0.90 0.40–2.10 0.79 83.4 0.94 0.35–2.57 0.891 81.5 0.93 0.37–2.32 0.88 43.8 0.91 0.33–1.2.49 0.86 84.3 0.98 0.57–1.69 0.95 0
PD Total 2 1.38 0.77–2.45 0.28 85.2 1.23 0.98–1.52 0.07 0 1.95 0.31–12.23 0.47 89.3 1.30 0.90–1.92 0.15 53.6 1.18 0.29–11.16 0.52 89.4
Rs4767944 T vs. C CT vs. CC TT vs. CC CT+TT vs. CC TT vs. CC+CT
PD Total 2 0.87 0.67–1.14 0.31 70.9 0.89 0.58–1.36 0.60 71.3 0.57 0.40–0.80 < 0.01 0 0.83 0.51–1.36 0.46 80.3 0.71 0.56–0.90 0.01 0